Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

(2013)   LANCET

ALDH1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD44 Expression, Drug Resistance, and Poor Clinical Outcome

(2012) Yu-Chi Wang et al.   AMERICAN JOURNAL OF PATHOLOGY

Modulation of Glucose Metabolism by CD44 Contributes to Antioxidant Status and Drug Resistance in Cancer Cells

(2012) M. Tamada et al.   CANCER RESEARCH

ErbB380kDa, a nuclear variant of the ErbB3 receptor, binds to the Cyclin D1 promoter to activate cell proliferation but is negatively controlled by p14ARF

(2012) Laëtitia Andrique et al.   CELLULAR SIGNALLING

A CD44−/CD24+ phenotype is a poor prognostic marker in early invasive breast cancer

(2011) Mohamed A. H. Ahmed et al.   BREAST CANCER RESEARCH AND TREATMENT

Therapeutic targeting of tumor–stroma interactions

(2011) Stephen Hiscox et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Hyaluronan Facilitates Transforming Growth Factor-β1-dependent Proliferation via CD44 and Epidermal Growth Factor Receptor Interaction

(2011) Soma Meran et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression

(2011) Rhonda L. Brown et al.   JOURNAL OF CLINICAL INVESTIGATION

Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype

(2011) S. Ricardo et al.   JOURNAL OF CLINICAL PATHOLOGY

Identification of CD44 as a Surface Biomarker for Drug Resistance by Surface Proteome Signature Technology

(2011) J. W. Cain et al.   MOLECULAR CANCER RESEARCH

Macropinocytosis inhibitors and Arf6 regulate ErbB3 nuclear localization in prostate cancer cells

(2011) Ismaël Hervé Koumakpayi et al.   MOLECULAR CARCINOGENESIS

Downregulation of CD44 reduces doxorubicin resistance of CD44+CD24- breast cancer cells

(2011) Pham Van Phuc et al.   OncoTargets and Therapy

Elevated Src kinase activity attenuates tamoxifen response in vitro and is associated with poor prognosis clinically.

(2010) Liam Morgan et al.   CANCER BIOLOGY & THERAPY

c-Met and Its Ligand Hepatocyte Growth Factor/Scatter Factor Regulate Mature B Cell Survival in a Pathway Induced by CD74

(2010) M. Gordin et al.   JOURNAL OF IMMUNOLOGY

RHAMM/ERK interaction induces proliferative activities of cementifying fibroma cells through a mechanism based on the CD44–EGFR

(2010) Hiroko Hatano et al.   LABORATORY INVESTIGATION

A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis

(2009) M. Tremmel et al.   BLOOD

Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities

(2009) B. P. Toole   CLINICAL CANCER RESEARCH

Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion

(2009) Alaa Afify et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Expression of a phosphorylated p130Cassubstrate domain attenuates the phosphatidylinositol 3-kinase/Akt survival pathway in tamoxifen resistant breast cancer cells

(2009) Shefali Soni et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

EGFR and ErbB2 are functionally coupled to CD44 and regulate shedding, internalization and motogenic effect of CD44

(2008) Zsuzsanna Pályi-Krekk et al.   CANCER LETTERS

Mislocalization of cell–cell adhesion complexes in tamoxifen-resistant breast cancer cells with elevated c-Src tyrosine kinase activity

(2008) Yan Zhao et al.   CANCER LETTERS

DNA vaccination with CD44 variant isoform reduces mammary tumor local growth and lung metastasis

(2008) Shulamit Batya Wallach-Dayan et al.   MOLECULAR CANCER THERAPEUTICS

Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression

(2008) Lilly Y.W. Bourguignon   SEMINARS IN CANCER BIOLOGY